‘Pineapple’ treatment for burn wounds
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The CHMP has recommended the first medical treatment for the removal of eschar from severe burn wounds.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The CHMP has recommended the first medical treatment for the removal of eschar from severe burn wounds.
by Maria Dalby – Donating a kidney in later life can have a positive effect on quality of life, according to the largest study to date on this… read more.
by Maria Dalby – The first face transplantation to be performed in the USA took place at the Cleveland Clinic in December 2008.
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.
Sleep apnoea severity has been associated with increased cancer mortality in a new study.
“Exposure to media coverage of terrorist missile attacks increases pain levels in people already suffering from chronic pain,” according to a new study by Ben-Gurion University of the… read more.
“Exposure to media coverage of terrorist missile attacks increases pain levels in people already suffering from chronic pain,” according to a new study by Ben-Gurion University of the… read more.
Women having surgery for breast cancer are up to three times more likely to have severe pain in the first week after surgery if they suffer from other… read more.
Researchers from Mount Sinai School of Medicine have identified reliable predictors of pain by surveying patients throughout their hospital stays about the severity of their pain and their… read more.
The routine use of non-steroidal anti-inflammatory drugs (NSAIDs) among patients with ankylosing spondylitis can slow the progression of bone changes in the spine, two groups of European researchers… read more.
When people have similar injuries, why do some end up with chronic pain while others recover and are pain free? The first longitudinal brain imaging study to track… read more.
The combination also appears to be cost effective. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.